Helio.com

The FDA has granted breakthrough therapy designation for litifilimab in patients with cutaneous lupus erythematosus, according to a press release […]

LAS VEGAS — Effective mentorship can accelerate careers, but toxic mentoring behaviors can just as easily derail academic progress if

Patients with fibromyalgia who used cannabis-based medicinal products demonstrated modest, medium-term improvements in pain, anxiety and sleep, according to data

More than 140 U.S. medical organizations are advocating for the passage of a bill that would increase NIH funding for

Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly 70% remain hesitant on whether its efficacy outweighs the

Patients will soon have the option to integrate their medical records with popular AI programs, highlighting new dangers along with

The FDA has granted breakthrough therapy designation to Novartis’ ianalumab for Sjögren’s disease, according to a press release from the

In this Healio video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, highlights a recent Q&A with

President Donald J. Trump announced a health care framework that he said will lower drug prices and insurance premiums and

An FDA draft guidance nixing the requirement for biosimilar manufacturers to conduct comparative efficacy studies may prove “consequential” in reducing

Yale School of Public Health recently unveiled a platform that offers reliable, real-time, synthesized health data directly to the public,

Maternal exposure to TNF inhibition does not significantly increase infection risk in newborns, according to findings published in Arthritis &

The optimal hydroxychloroquine blood level in lupus is between 750 ng/mL and 1,150 ng/mL, which can help prevent active disease

Combination therapy with ixekizumab and tirzepatide bested monotherapy with ixekizumab alone in both psoriatic arthritis and weight reduction endpoints, according

The ever-shifting political landscape in the United States has made advocacy a critical component — and challenge — for every

An advisory board comprised of 14 physicians and health care experts will be part of Healio AI’s ongoing development, providing

Mortality due to hemophagocytic lymphohistiocytosis nearly doubled across 29 European countries from 2011 to 2021, according to findings published in

Emergency physicians cheered last September when “The Pitt” won five Emmy Awards, including for best drama.They “felt seen and heard”

Telitacicept, a dual inhibitor of the cytokines B-lymphocyte stimulator and a proliferation-inducing ligand, showed efficacy in systemic lupus erythematosus vs.

Pegcetacoplan significantly reduces proteinuria in patients with recurrent C3 glomerulopathy, or primary immune-complex membranoproliferative glomerulonephritis, compared with placebo, according to

A history of foot or ankle injury is a major risk factor for osteoarthritis in those joints among former soccer

Exposure to occupational inhalants such as silica, pesticides, asbestos, solvents, fertilizers, animal dust and engine exhaust may increase the risk

State-level social welfare policies may address disparities in arthritis-related joint pain prevalence and education for patients from certain geographic areas,

In this Healio video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, highlights the potentially “disruptive” entry

Self-reported knee crepitus may predict osteoarthritis 1 year following ACL reconstruction, according to findings published in Arthritis Care & Research.“Knee

Like many physicians at this fraught time in medicine, I am watching television news now more than ever.Health care is

CHICAGO — Neuroimmune modulation inhibited progression of structural damage in patients with rheumatoid arthritis who had inadequate response or intolerance